Global Pharmaceutical Excipients Market is valued at USD 7687.1 Million in 2020 and expected to reach USD 11635.0 Million by 2027 with the CAGR of 6.1% over the forecast period.
Global Pharmaceutical Excipients Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027- Increasing growth of biopharmaceutical industry, growing incidences of chronic diseases and increasing number of R&D activities are some of the major factors driving the growth of Global Pharmaceutical excipients Market.
Excipients are a vital component of pharmaceutical items that basically decide the structure of dosage type and its part in conveying drugs. Excipients altogether influence the method capacity, aesthetics, productivity, and patient consistence with the dosage form. It is a natural or synthetic substance detailed with the dynamic element of a medication which include in a pharmaceutical dosage structure to help the assembling process to ensure, support, improve security or for bioavailability or patient acceptability. They likewise referred as a bulking agent, filler, or diluent. Pharmaceutical excipients are additionally useful in item identification and upgrade the general safety or usefulness of the item during storage or use. Flavoring specialists and sugars and coloring agents are utilized to upgrade the stylish nature of detailing and improve the simplicity of organization among patients. The requirement of fillers is more inside the last formulation. Inorganic chemicals and natural chemicals are the key pharmaceutical excipients.
The COVID-19 pandemic essentially affected the pharma business. During COVID-19 pandemic, government of multiple nations imposed a lockdown which disturbed the supply of raw materials from manufacturing centers. This slows down the drug development and manufacturing, with extreme effects on organizations that depended vigorously on outsourcing. The whole pharmaceutical system was disturbed due to the restriction on transportation and social distancing measures. However, post COVID-19, the finish of the lockdowns saw the pharma business acquiring momentum, particularly given the demand for drugs like hydroxychloroquine and Remdesivir, which showed positive outcomes against COVID-19. The rising demand for these medications drove income development for certain organizations.
Global pharmaceutical excipients market is segmented on the basis of product, functionality, application and region & country level. On the basis of product, the pharmaceutical excipients market is classified as organic chemicals, inorganic chemicals and others. On the basis of functionality, the market is classified as fillers and diluents, suspending and viscosity agents, coating agents, binders, flavoring agents and sweeteners, colorants and other. On the basis of application, the market is classified as oral, topical, parenteral and other.
By Product:
By Functionality:
By Application:
The regions covered in global pharmaceutical excipients market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of pharmaceutical excipients market sub divided in U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Global pharmaceutical excipients market reports cover prominent players like Ashland Global Holdings, BASF SE, DuPont, Roquette Feres, Evonik Industries AG, Associated British Foods, Archer Daniels Midland Company, Lubrizol Corporation, Croda International, Innophous Holdings, Kerry Group, WACKER Chemie AG, Colorcon, DFE Pharma, JRS Pharma, and Air Liquide and others.
News: DFE Pharma to Launch New Biopharma Excipient Solution
April 22nd, 2021; DFE Pharma, a pharmaceutical excipient solutions company located in Germany, has launched BioHale, a new product line aimed at addressing worldwide supply challenges for biopharmaceutical companies According to a company press release, the new line will offer market purity and low endotoxin excipients for use in formulation, while providing drug developers and manufacturers with high quality excipient technology and services to advance therapeutic formulation.
Growing Biopharmaceutical Industry, Growing Incidences of Chronic Diseases and Increasing Number of R&D Activities are Driving the Market Growth
One of the major factors driving the growth of global pharmaceutical excipients market is growing biopharmaceuticals industry. For instance; Food and Drug Administration (FDA) approved 38 new medications each year from 2010 through 2019 (with a pinnacle of 59 of every 2018), which is 60% more than the yearly normal over the earlier decade. In addition, the growth of global pharmaceutical excipients market is due to growing incidences of chronic diseases are also increasing the demand for medicines and driving the demand for pharmaceutical excipients. For instance; according to the World Health Organization (WHO), chronic disease occurrence is expected to grow by 57% by the year 2020. Furthermore, increasing number of R&D activities drives the global pharmaceutical excipients market. For example, Evonik's recently launched EUDRAGIT FS 100 is a strong variant of the current EUDRAGIT FS 30 D. This new multi-functional adaptation permits pharmaceutical organizations to utilize the polymer in numerous new applications, like hot-melt expulsion, solvent coating, and solvent spray drying, which was difficult to accomplish in past many years where just the fluid form was accessible.
However, cost and time-intensive drug development procedure may hamper the growth of global pharmaceutical excipients market. In spite of that, changing focus of pharmaceutical manufacturing to emerging countries can offer more opportunities for the further growth of the global pharmaceutical excipients market.
Europe is anticipated to expected to show a significant growth in the global pharmaceutical excipients market due to the technological advancement, growing investments for the development of biologics and superior dosage forms and presence of key players in this region. For instance; in 2020, Evonik dispatched the EUDRATEC Fasteric discharges, a high level oral drug conveyance innovation that gives enteric protection followed by quick, homogeneous release for viable focusing of the upper small intestine. In 2018, Roquette signed to a deal with Thermo Fisher. Roquette signed to an arrangement with ThermoFisher Scientific, which gives Thermo the right to appropriate Roquette's items in the US and Canada. This will give further market access to Roquette. Asia-Pacific region is expected to show the fastest growth in the global pharmaceutical excipients market due to the rising population and growing biopharmaceuticals industry in this region.
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®